Seung KJ, Khan UT, Varaine FFV, Ahmed SM, Bastard M, et al.
2020-10-01 • International Journal of Tuberculosis and Lung Disease
2020-10-01 • International Journal of Tuberculosis and Lung Disease
In 2015, the initiative Expand New Drug Markets for TB (endTB) began, with the objective of reducing barriers to access to the new and repurposed TB drugs. Here we describe the major imp...
du Cros PAK, Swaminathan A, Bobokhojaev O, Sharifovna ZD, Martin C, et al.
2015-06-21 • Public Health Action
2015-06-21 • Public Health Action
Guidelines for children with drug-resistant tuberculosis (DR-TB) tend to focus on individual patient care; there is little guidance for national tuberculosis programmes (NTPs) on how to...
Achar J, Hewison CCH, Cavalheiro AP, Skrahina A, Cajazeiro J, et al.
2017-10-01 • Emerging Infectious Diseases
2017-10-01 • Emerging Infectious Diseases
We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessati...
du Cros PAK, Khamraev AK, Tigay Z, Abdrasuliev T, Greig J, et al.
2021-02-08 • ERJ open research
2021-02-08 • ERJ open research
BACKGROUND In 2016, World Health Organization guidelines conditionally recommended standardised shorter 9–12-month regimens for multidrug-resistant (MDR) tuberculosis (TB) treatment....
